Organ preservation: current limitations and optimization approaches

Qiulin Ran1, Jiayi Zhang2, Jisheng Zhong1

  • 1Department of Cardiovascular Surgery, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Frontiers in Medicine
|April 10, 2025
PubMed

Insights

Organ transplantation faces graft shortages due to preservation issues. Machine perfusion (MP) offers a promising alternative to static cold storage (SCS) for improving graft viability and transplant outcomes.

Area of Science:

  • Transplantation immunology
  • Organ preservation science
  • Regenerative medicine

Background:

  • Graft scarcity limits organ transplantation, driven by donor limitations, preservation challenges, and immunologic mismatch.
  • Current static cold storage (SCS) faces limitations including cold-induced injury, solution toxicity, and exacerbation of reperfusion injury.
  • Marginal organs and extended criteria donors (ECD) present challenges for traditional preservation methods.

Purpose of the Study:

  • To review advancements in organ preservation techniques, focusing on static cold storage (SCS) and dynamic machine perfusion (MP).
  • To elucidate injury mechanisms associated with SCS and explore optimization strategies.
  • To highlight the potential of MP in enhancing graft utilization and post-transplant outcomes.

Main Methods:

  • Comprehensive literature review of organ preservation strategies, including cryopreservation, subzero non-freezing storage, SCS, and MP.
  • Analysis of injury mechanisms inherent to SCS.
  • Evaluation of MP technologies and their benefits for graft viability and repair.

Main Results:

  • SCS, while cost-effective, can induce cold injury and fails to address reperfusion damage.
  • Dynamic machine perfusion (MP) preserves organs in a near-physiological state, allowing for viability assessment and damage repair.
  • MP is increasingly adopted, especially for ECDs, offering improved outcomes compared to SCS.

Conclusions:

  • Advancements in MP technology are crucial for overcoming limitations of SCS and improving organ transplant success.
  • Understanding SCS injury mechanisms can inform the optimization of MP protocols.
  • MP holds significant promise for expanding the donor pool and enhancing graft survival rates.